Details as on September 30, 2021 |
An open ended scheme replicating/tracking Nifty 50 Value 20 Index
The Scheme employs a passive investment approach designed to track the performance of Nifty 50 Value 20 TRI.The Scheme seeks to achieve this goal by investing in securities constituting the Nifty 50 Value 20 Index in same proportion as in the Index.
February 19, 2021
Mehul Dama
Nifty 50 Value 20 TRI
Monthly Average : | ₹ 52.52 Cr |
Month End : | ₹ 56.32 Cr |
Growth Plan | ₹ 12.5262 |
IDCW Plan | ₹ 12.5262 |
Direct - Growth Plan | ₹ 12.5749 |
Direct - IDCW Plan | ₹ 12.5749 |
Entry Load: | Nil |
Exit Load: | Nil
|
Regular/Other than Direct | 0.80 |
Direct | 0.20 |
Company/Issuer | % of Assets |
Auto | |
Bajaj Auto Limited | 2.09 |
Hero MotoCorp Limited | 1.54 |
Banks | |
IndusInd Bank Limited | 2.82 |
Cement & Cement Products | |
Grasim Industries Limited | 2.67 |
Construction Project | |
Larsen & Toubro Limited* | 8.63 |
Consumer Non Durables | |
Hindustan Unilever Limited* | 10.12 |
ITC Limited* | 8.67 |
Ferrous Metals | |
JSW Steel Limited | 2.78 |
Minerals/Mining | |
Coal India Limited | 1.63 |
Non - Ferrous Metals | |
Hindalco Industries Limited* | 2.99 |
Oil | |
Oil & Natural Gas Corporation Limited | 2.21 |
Pesticides | |
UPL Limited | 1.63 |
Pharmaceuticals | |
Sun Pharmaceutical Industries Limited* | 3.71 |
Power | |
NTPC Limited | 2.83 |
Power Grid Corporation of India Limited | 2.72 |
Software | |
Tata Consultancy Services Limited* | 14.81 |
Infosys Limited* | 14.65 |
HCL Technologies Limited* | 5.83 |
Wipro Limited* | 3.94 |
Tech Mahindra Limited* | 3.60 |
Cash and Other Receivables | 0.13 |
Grand Total | 100.00 |
*Top 10 Holdings
This product is suitable for investors who are seeking*:
• Long term capital growth
• Investment in equity and equity related securities and portfolio replicating the composition of the
Nifty 50 Value 20 Index, subject to tracking errors
Fund Riskometer
Nippon India Nifty 50 Value 20 Index Fund
Benchmark Riskometer
Nifty 50 Value 20 TRI
* Investors should consult their financial advisers if in doubt about whether the product is suitable for them.